Who
Richard James Whitley
Director
Company insider
Files Form 4 as: Director, Dogwood Therapeutics; Director, Gilead Sciences.
In numbers
- Trades disclosed
- 141
- Buys
- 3
- Sells
- 20
- Bought
- $14K
- Sold
- $9.7M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 30 Jul 2008
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,800 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,800 at $0.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,362 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —210 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —210 at $0.00 | filing |
| 26 Feb 2024filed 28 Feb 2024 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,250 at $0.00 | filing |
| 8 Dec 2022filed 12 Dec 2022 | DWTX Dogwood TherapeuticsBiotechnology | SEC FORM 4 Sold | $4681,800 at $0.26 | filing |
| 23 Jun 2022filed 30 Jun 2022 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,250 at $0.00 | filing |
| 18 May 2022filed 19 May 2022 | DWTX Dogwood TherapeuticsBiotechnology | SEC FORM 4 Bought | $2,265500 at $4.53 | filing |
| 6 Jan 2022filed 7 Jan 2022 | DWTX Dogwood TherapeuticsBiotechnology | SEC FORM 4 Bought | $10K1,800 at $5.72 | filing |
| 23 Dec 2021filed 23 Dec 2021 | DWTX Dogwood TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,146200 at $5.73 | filing |
| 22 Jun 2021filed 23 Jun 2021 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,875 at $0.00 | filing |
| 6 May 2021filed 7 May 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,936 | filing |
| 6 May 2021filed 7 May 2021 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —1,936 | filing |
| 3 May 2021filed 4 May 2021 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | $419K20,282 at $20.65 | filing |
| 3 May 2021filed 4 May 2021 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Sold | $1.3M20,282 at $64.57 | filing |
| 3 May 2021filed 4 May 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,282 at $0.00 | filing |
| 30 Mar 2021filed 31 Mar 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —62.96 at $0.00 | filing |
| 30 Dec 2020filed 4 Jan 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —68.9 at $0.00 | filing |
News
Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?GILD · fool.com · 18 Oct 2026Gilead Sciences Clears Its February High at $153.54GILD · 247wallst.com · 15 Oct 2026Dogwood Therapeutics, Inc (NASDAQ:DWTX) Sees Significant Drop in Short InterestDWTX · themarketsdaily.com · 14 Oct 2026Gilead Sciences, Inc. $GILD Stock Acquired by First Citizens Bank & Trust Co.GILD · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Richard James Whitley; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.